Results 21 to 30 of about 93,278 (263)

Impact of COVID-19 epidemic on antihypertensive drug treatment disruptions: results from a nationwide interrupted time-series analysis

Frontiers in Pharmacology, 2023
Background: The COVID-19 epidemic has disrupted care and access to care in many ways. It was accompanied by an excess of cardiovascular drug treatment discontinuations.
Clément Mathieu, Julien Bezin, Julien Bezin, Antoine Pariente, Antoine Pariente   +4 more
doaj   +1 more source

Choice of treatment based on Turkish hypertension consensus report: Do we follow the recommendations?

Türk Kardiyoloji Derneği Arşivi, 2018
Objective: The aim of this study was to determine how often the recommendations of the Turkish Hypertension Consensus Report are followed, and to draw attention to the report.
Gülden Yürüyen, İlkim Deniz Toprak, Zeki Toprak, Murat Akarsu, Pınar Demir, Yücel Arman, Eylem Özgün Çil, Mustafa Özcan, Sedat Irmak, Özgür Altun, Şengül Aydın Yoldemir, Hasan Eruzun, Tufan Tükek   +12 more
doaj   +1 more source

A comparative study of antihypertensive drugs prediction models for the elderly based on machine learning algorithms

Frontiers in Cardiovascular Medicine, 2022
BackgroundGlobally, blood pressure management strategies were ineffective, and a low percentage of patients receiving hypertension treatment had their blood pressure controlled.
Tiantian Wang, Yongjie Yan, Shoushu Xiang, Juntao Tan, Chen Yang, Wenlong Zhao   +5 more
doaj   +1 more source

Outpatient antihypertensive drug utilization in Canton Sarajevo during five years period (2004-2008) and adherence to treatment guidelines assessment

Biomolecules & Biomedicine, 2011
Hypertension is chronic disease with high prevalence, which can successfully be treated with antihypertensive drugs. Previous researches have shown that existing hypertension treatment guidelines are not fully implemented in practice.
Tarik Čatić, Begler Begović
doaj   +1 more source

Design, Formulation, and Characterization of Valsartan Nanoethosomes for Improving Their Bioavailability

Pharmaceutics, 2022
The objective of this study was to formulate and evaluate valsartan (VLT) ethosomes to prepare an optimized formula of VLT-entrapped ethosomes that could be incorporated into a sustained release transdermal gel dosage form.
Ali M. Nasr, Fayrouz Moftah, Mohammed A. S. Abourehab, Shadeed Gad   +3 more
doaj   +1 more source

Synthesis and Antifungal Activity of 1,2,4-Oxadiazole Derivatives

Molecules
1,2,4-Oxadiazole derivatives containing anisic acid or cinnamic acid were designed and synthesized, which were expected to be an effective Succinate dehydrogenase (SDH) inhibitor, and their structures were characterized by 1H NMR, 13C NMR, and ESI-MS ...
Lili Yu, Kuan Yang, Lin Yao, Nana Wang, Hui Kang, Guangda Yao, Xiaomeng Li, Bei Qin   +7 more
doaj   +1 more source

The Profile of Antihypertensive Drug Prescriptions and Interactions at Pindad General Hospital

Pharmacology and Clinical Pharmacy Research, 2020
Hypertension is a major problem in the world. World Health Organization (WHO) reported that 1.13 billion people in the world suffer from hypertension. This study aimed to determine antihypertensive prescription profile and drug interaction in outpatient ...
Yane S. Herliany, Siti R. Wahyuningsih
doaj   +1 more source

卒中患者血压水平与卒中后认知障碍关系的研究进展 Progress of Blood Pressure and Post-stroke Cognitive Impairment

Zhongguo cuzhong zazhi, 2023
卒中后认知障碍为卒中的常见并发症之一，可严重影响卒中患者的生活质量及预后。目前认为血压与卒中后认知障碍密切相关，血压可能对卒中后认知障碍的主要病理生理过程产生潜在影响，并且控制血压可能有助于卒中后认知障碍的改善或预防。血压与卒中后认知障碍之间的相关性较为复杂，可能取决于特定的血压参数和卒中的不同阶段。目前卒中后的最佳血压控制水平尚不统一。本文对卒中后认知障碍的流行病学，血压与卒中后认知障碍的相关性，血压影响卒中后认知障碍的相关机制，以及控制血压的作用进行综述 ...
吴雅婷,魏宸铭,武剑
doaj   +1 more source

Antihypertensive drugs

Pharmacological Research, 2017
Successful treatment of hypertension is possible with limited side effects given the availability of multiple antihypertensive drug classes. This review describes the various pharmacological classes of antihypertensive drugs, under two major aspects: their mechanisms of action and side effects.
openaire   +2 more sources

Efficacy, safety and Cardiovascular Disease Risk Lowering Ability of ACE Inhibitors, B-Blockers and Combination Antihypertensive Drug Regimes in Iraq

Iraqi Journal of Pharmaceutical Sciences, 2017
Hypertension is a major health problem throughout the world because of its high prevalence and its association with increased risk of cardiovascular diseases.
Dlveen M. Sulaiman, Kassim J.Al-Shamma, Ansam N.Al-Hassani   +2 more
doaj   +1 more source